A Cross-Country Index of Intellectual Property Rights in Pharmaceutical Innovations
Many countries with strong patent protection for other industrial products and processes have not always provided strong protection for pharmaceutical innovations. For example, in 1970, all 22 OECD countries had functioning industrial patent systems, but only four allowed new pharmaceutical products to be patented. Over the last five decades, the extent of IPR protection for […]
Read More